← Back
$APLT All transactions

Applied Therapeutics, Inc.

D

$ Value

Shares

22,500

Price

Filed

Feb 3

Insider

Name

SKYLER JAY S

Title

CIK

0001236386

Roles

Director

Transaction Details

Transaction Date

2026-02-03

Code

D

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

42,500

Footnotes

Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement") dated as of December, 11, 2025, among the Issuer, Cycle Group Holdings Limited and AT2B, INC. ("Purchaser"), Purchaser completed a tender offer for shares of Issuer and thereafter merged with and into the Issuer (the "Merger"), effective as of January 28, 2026, with the Issuer surviving the Merger. At the effective time of the Merger (the "Effective Time"), each outstanding share of Issuer common stock was cancelled and converted into the right to receive (i) $0.088 per share of common stock, net to the seller in cash, without interest (the "Closing Amount") plus (ii) one non-tradeable contingent value right, in accordance with the terms and subject to the conditions of a contingent value rights agreement (the "Merger Consideration"). | Pursuant to the Merger Agreement, at the Effective Time, each outstanding RSU (whether vested or unvested) was deemed to have vested and was cancelled and automatically converted into the right to receive the Merger Consideration. | Pursuant to the Merger Agreement, each share of common stock tendered by the Reporting Person was tendered in exchange for the Merger Consideration. | Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of common stock (each a "Stock Option") that has a per share exercise price that equals or exceeds the Closing Amount as of immediately prior to the Effective time (each such Stock Option, an "Out-of-the-Money Option"), to the extent not vested, was fully vested as of prior to the Effective Time. Any Out-of-the-Money Options that remained outstanding and unexercised as of the Effective Time were cancelled for no consideration at the Effective Time.

Filing Info

Accession No.

0001193125-26-036147

Form Type

4

Issuer CIK

0001697532

SKYLER JAY S's History

Date Ticker Type Value
2026-02-03 APLT D
2026-02-03 APLT U
2026-02-03 APLT D
2026-02-03 APLT D
2026-02-03 APLT D
2026-02-03 APLT D
2026-02-03 APLT D
2025-12-16 SABS A $0
2025-06-09 APLT A $0

Other Insiders at APLT (90d)

Insider Bought Sold Last
SKYLER JAY S 2026-02-03
Hooks Corwin Dale
Chief Commercial Officer
2026-02-03
Funtleyder Leslie D.
Chief Financial Officer
2026-02-03
Lerner Teena 2026-02-03
Kanter Stacy J. 2026-02-03
Chinoporos Constantine
See Remarks
2026-02-03
Bailey Evan Prescott
Chief Medical Officer
2026-02-03